When to Stop Surveillance: Pancreatic Cysts.

Area of Science:

• Gastroenterology
• Oncology
• Medical Imaging

Background:

• Pancreatic cysts, particularly branch-duct intraductal papillary mucinous neoplasms (IPMNs), require careful surveillance to mitigate pancreatic cancer risk.
• Management guidelines for high-risk cysts are established, but discontinuing surveillance for low-risk IPMNs remains a clinical challenge.

Purpose of the Study:

• To provide evidence-based recommendations for discontinuing surveillance in patients with low-risk branch-duct IPMNs.
• To establish clear criteria for the cessation of long-term monitoring of pancreatic cysts.

Main Methods:

• Review of up-to-date evidence regarding the natural history and stability of pancreatic cysts.
• Analysis of cyst size and interval stability as key factors for surveillance decisions.

Main Results:

• Discontinuation of surveillance is supported for low-risk IPMNs based on cyst stability and size.
• Recommendations include cessation of follow-up at 5 or 10 years, depending on these criteria.

Conclusions:

• Oversurveillance of pancreatic cysts lacking high-risk features is discouraged.
• Cessation of surveillance for stable, low-risk IPMNs is a safe and recommended practice.
• Adherence to size and stability criteria can optimize patient management and reduce healthcare burden.